Literature DB >> 21527536

DARTs take aim at BiTEs.

Christoph Rader1.   

Abstract

Year:  2011        PMID： 21527536     DOI： 10.1182/blood-2011-02-337691

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  28 in total

1.  New insights into effective targeted therapy for the treatment of adult acute lymphoblastic leukemia.

Authors:  Xavier Thomas
Journal:  Int J Hematol Oncol       Date:  2017-05-18

Review 2.  Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?

Authors:  Maximilian Stahl; Benjamin Y Lu; Tae Kon Kim; Amer M Zeidan
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

Review 3.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

Review 4.  Emerging therapies for acute myeloid leukemia: translating biology into the clinic.

Authors:  Simon Kavanagh; Tracy Murphy; Arjun Law; Dana Yehudai; Jenny M Ho; Steve Chan; Aaron D Schimmer
Journal:  JCI Insight       Date:  2017-09-21

Review 5.  Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.

Authors:  Dalal AlDeghaither; Brandon G Smaglo; Louis M Weiner
Journal:  J Clin Pharmacol       Date:  2015-03       Impact factor: 3.126

6.  Chemically programmed bispecific antibodies that recruit and activate T cells.

Authors:  Huiting Cui; Joshua D Thomas; Terrence R Burke; Christoph Rader
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

Review 7.  Mechanisms of action of therapeutic antibodies for cancer.

Authors:  J M Redman; E M Hill; D AlDeghaither; L M Weiner
Journal:  Mol Immunol       Date:  2015-04-23       Impact factor: 4.407

8.  Chemically Programmed Bispecific Antibodies in Diabody Format.

Authors:  Even Walseng; Christopher G Nelson; Junpeng Qi; Alex R Nanna; William R Roush; Rajib K Goswami; Subhash C Sinha; Terrence R Burke; Christoph Rader
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

9.  Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.

Authors:  Patrick Schlegel; Peter Lang; Gerhard Zugmaier; Martin Ebinger; Hermann Kreyenberg; Kai-Erik Witte; Judith Feucht; Matthias Pfeiffer; Heiko-Manuel Teltschik; Christina Kyzirakos; Tobias Feuchtinger; Rupert Handgretinger
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

10.  Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.

Authors:  Julia A M Sung; Joy Pickeral; Liqin Liu; Sherry A Stanfield-Oakley; Chia-Ying Kao Lam; Carolina Garrido; Justin Pollara; Celia LaBranche; Mattia Bonsignori; M Anthony Moody; Yinhua Yang; Robert Parks; Nancie Archin; Brigitte Allard; Jennifer Kirchherr; JoAnn D Kuruc; Cynthia L Gay; Myron S Cohen; Christina Ochsenbauer; Kelly Soderberg; Hua-Xin Liao; David Montefiori; Paul Moore; Syd Johnson; Scott Koenig; Barton F Haynes; Jeffrey L Nordstrom; David M Margolis; Guido Ferrari
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.